ROOSEVELT GENERAL HOSPITAL — History
CCN 320084 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$36M
Latest Revenue (FY2022)
+18.5%
Revenue CAGR (3yr)
-25.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $26M | $36M | $36M | +1.7% | +18.5% |
| Operating Expenses | $35M | $41M | $46M | +12.5% | +14.4% |
| Operating Margin | -34.4% | -13.2% | -25.1% | -91.1% | +0.0% |
| Net Income | $-9M | $-5M | $-9M | -94.4% | +0.0% |
| Licensed Beds | 12 | 12 | 12 | +0.0% | +0.0% |
| Total Patient Days | 838 | 1,634 | 667 | -59.2% | -10.8% |
| Medicare Day % | 48% | 35% | 40% | +15.6% | -8.3% |
| Medicaid Day % | 1% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +40.5% ($26M → $36M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+18.5%
This Hospital
+7.6%
State Avg
Latest Margin
-25.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $42M | -20.5% |
| FY2024 (proj) | $47M | -15.9% |
| FY2025 (proj) | $52M | -11.3% |